Related Experiment Videos
Nursing care for survivors of sudden cardiac death
Abstract:
The development of four new antiarrhythmic drugs offers promise for the treatment of patients who survive an episode of sudden cardiac death. Medical treatment, however, remains somewhat empirical, reflecting continued lack of total understanding of arrhythmogenesis and the pharmacokinetic properties of drugs required for suppression and control of arrhythmias. Further, although the value of such treatment cannot be underestimated, a healthy respect for the potential risk of arrhythmia aggravation by all of these drugs is warranted. The management of these patients presents a tremendous challenge for both physicians and nurses: physicians are responsible primarily for the definition of type, location, and severity of the arrhythmia; nurses focus primarily on the patient's response to illness and treatment in terms of its potential impact on their lifestyle. The clear focus for each discipline is necessary for development of a more purposeful and comprehensive treatment plan for the patient. As survival of sudden cardiac death increases, a number of patient responses, emotional and physical, have been noted clinically. The concept of nursing diagnosis can serve as a frame of reference from which nurses can begin to more scientifically evaluate their impact on patient care. Most importantly, it will contribute to an improvement in the care of patients whose lives have been so disrupted by the unpredictable nature of the arrhythmia and the investigational nature of treatment.
Insights
New antiarrhythmic drugs show promise for sudden cardiac death survivors, but treatment remains empirical due to incomplete understanding of arrhythmias. Careful management by physicians and nurses is crucial for patient well-being.
Area of Science:
- Cardiology
- Pharmacology
- Nursing
Background:
- Sudden cardiac death survivors require effective antiarrhythmic treatments.
- Current antiarrhythmic drug therapy is limited by incomplete understanding of arrhythmogenesis and drug pharmacokinetics.
- All antiarrhythmic drugs carry a risk of potentially aggravating arrhythmias.
Purpose of the Study:
- To highlight the promise of four new antiarrhythmic drugs for patients surviving sudden cardiac death.
- To emphasize the challenges in managing these patients, requiring collaboration between physicians and nurses.
- To explore the role of nursing diagnosis in improving patient care and managing treatment impacts.
Main Methods:
- Review of current literature on antiarrhythmic drug development and patient management.
- Analysis of the roles and responsibilities of physicians and nurses in arrhythmia care.
- Discussion of the application of nursing diagnosis in evaluating patient responses to illness and treatment.
Main Results:
- Four new antiarrhythmic drugs offer potential therapeutic benefits.
- Effective patient management necessitates a clear delineation of physician and nursing roles.
- Nursing diagnosis provides a framework for scientifically evaluating nursing interventions and patient outcomes.
Conclusions:
- Despite advancements, antiarrhythmic treatment requires further research into underlying mechanisms and drug properties.
- Interdisciplinary collaboration is essential for comprehensive patient care plans.
- Integrating nursing diagnosis can enhance the scientific evaluation of nursing's impact on patient recovery and lifestyle adaptation.